{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T23:37:25Z","timestamp":1784590645750,"version":"3.55.0"},"reference-count":32,"publisher":"Japanese Society of Veterinary Science","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Vet. Med. Sci.","The Journal of Veterinary Medical Science"],"published-print":{"date-parts":[[2019]]},"DOI":"10.1292\/jvms.19-0399","type":"journal-article","created":{"date-parts":[[2019,10,27]],"date-time":"2019-10-27T22:03:33Z","timestamp":1572213813000},"page":"1753-1762","source":"Crossref","is-referenced-by-count":8,"title":["Protective efficacy of inactivated reverse genetics based equine influenza vaccine candidate adjuvanted with Montanide&lt;sup&gt;TM&lt;\/sup&gt; Pet Gel in murine model"],"prefix":"10.1292","volume":"81","author":[{"given":"Manu Kurian","family":"MATHEW","sequence":"first","affiliation":[{"name":"ICAR-National Research Centre on Equines, Sirsa Road, Hisar-125 001, Haryana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"VIRMANI","sequence":"additional","affiliation":[{"name":"ICAR-National Research Centre on Equines, Sirsa Road, Hisar-125 001, Haryana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bidhan Chandra","family":"BERA","sequence":"additional","affiliation":[{"name":"ICAR-National Research Centre on Equines, Sirsa Road, Hisar-125 001, Haryana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taruna","family":"ANAND","sequence":"additional","affiliation":[{"name":"ICAR-National Research Centre on Equines, Sirsa Road, Hisar-125 001, Haryana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh","family":"KUMAR","sequence":"additional","affiliation":[{"name":"Lala Lajpat Rai University of Veterinary & Animal Sciences, Hisar-125004 Haryana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkataramireddy","family":"BALENA","sequence":"additional","affiliation":[{"name":"ICAR-National Research Centre on Equines, Sirsa Road, Hisar-125 001, Haryana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rekha","family":"SANSANWAL","sequence":"additional","affiliation":[{"name":"ICAR-National Research Centre on Equines, Sirsa Road, Hisar-125 001, Haryana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selvaraj","family":"PAVULRAJ","sequence":"additional","affiliation":[{"name":"ICAR-National Research Centre on Equines, Sirsa Road, Hisar-125 001, Haryana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthik","family":"SUNDARAM","sequence":"additional","affiliation":[{"name":"ICAR-National Research Centre on Equines, Sirsa Road, Hisar-125 001, Haryana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meenakshi","family":"VIRMANI","sequence":"additional","affiliation":[{"name":"Lala Lajpat Rai University of Veterinary & Animal Sciences, Hisar-125004 Haryana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhupendra Nath","family":"TRIPATHI","sequence":"additional","affiliation":[{"name":"ICAR-National Research Centre on Equines, Sirsa Road, Hisar-125 001, Haryana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"122","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Benne, C. A., Harmsen, M., van der Graaff, W., Verheul, A. F., Snippe, H. and Kraaijeveld, C. A. 1997. Influenza virus neutralizing antibodies and IgG isotype profiles after immunization of mice with influenza A subunit vaccine using various adjuvants. <i>Vaccine<\/i> 15: 1039\u20131044.","DOI":"10.1016\/S0264-410X(96)00287-3"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Bhardwaj, N., Seder, R. A., Reddy, A. and Feldman, M. V. 1996. IL-12 in conjunction with dendritic cells enhances antiviral CD8+ CTL responses in vitro. <i>J. Clin. Invest.<\/i> 98: 715\u2013722.","DOI":"10.1172\/JCI118843"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Bhatia, S., Khandia, R., Sood, R., Bhat, S., Siddiqui, A., Jahagirdhar, G., Mishra, S., Mishra, A., Pateriya, A. K. and Kulkarni, D. D. 2016. Reverse genetics based rgH5N2 vaccine provides protection against high dose challenge of H5N1 avian influenza virus in chicken. <i>Microb. Pathog.<\/i> 97: 172\u2013177.","DOI":"10.1016\/j.micpath.2016.06.011"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Cauchard, S., Bertrand, F., Barrier-Battut, I., Jacquet, S., Laurentie, M., Barbey, C., Laugier, C., Deville, S. and Cauchard, J. 2014. Assessment of the safety and immunogenicity of Rhodococcus equi-secreted proteins combined with either a liquid nanoparticle (IMS 3012) or a polymeric (PET GEL A) water-based adjuvant in adult horses and foals\u2014identification of promising new candidate antigens. <i>Vet. Immunol. Immunopathol.<\/i> 157: 164\u2013174.","DOI":"10.1016\/j.vetimm.2013.12.003"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. de Wit, E., Munster, V. J., Spronken, M. I., Bestebroer, T. M., Baas, C., Beyer, W. E., Rimmelzwaan, G. F., Osterhaus, A. D. and Fouchier, R. A. 2005. Protection of mice against lethal infection with highly pathogenic H7N7 influenza A virus by using a recombinant low-pathogenicity vaccine strain. <i>J. Virol.<\/i> 79: 12401\u201312407.","DOI":"10.1128\/JVI.79.19.12401-12407.2005"},{"key":"6","unstructured":"6. Deville, S., Parker, R. and Laval, A. 2008. Adjuvant formulation for Influenza H1N1and H3N2 pig vaccines: Montanide Gel safety and efficacy study. Proceedings of the Conference of Research of Workers in Animal Diseases, Chicago."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Deville, S., Carneaux, E., Bertrand, F., Cauchard, S., Cauchard, J. and Dupuis, L. 2011. Adjuvant formulation for companion animals vaccines. <i>Procedia Vaccinol.<\/i> 4: 104\u2013112.","DOI":"10.1016\/j.provac.2011.07.015"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Dienz, O., Eaton, S. M., Bond, J. P., Neveu, W., Moquin, D., Noubade, R., Briso, E. M., Charland, C., Leonard, W. J., Ciliberto, G., Teuscher, C., Haynes, L. and Rincon, M. 2009. The induction of antibody production by IL-6 is indirectly mediated by IL-21 produced by CD4+ T cells. <i>J. Exp. Med.<\/i> 206: 69\u201378.","DOI":"10.1084\/jem.20081571"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Elton, D. and Cullinane, A. 2013. Equine influenza: antigenic drift and implications for vaccines. <i>Equine Vet. J.<\/i> 45: 768\u2013769.","DOI":"10.1111\/evj.12148"},{"key":"10","unstructured":"10. Germann, T., Bongartz, M., Dlugonska, H., Hess, H., Schmitt, E., Kolbe, L., K\u00f6lsch, E., Podlaski, F. J., Gately, M. K. and R\u00fcde, E. 1995. Interleukin-12 profoundly up-regulates the synthesis of antigen-specific complement-fixing IgG2a, IgG2b and IgG3 antibody subclasses in vivo. <i>Eur. J. Immunol.<\/i> 25: 823\u2013829."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Getahun, A., Dahlstr\u00f6m, J., Wernersson, S. and Heyman, B. 2004. IgG2a-mediated enhancement of antibody and T cell responses and its relation to inhibitory and activating Fc \u03b3 receptors. <i>J. Immunol.<\/i> 172: 5269\u20135276.","DOI":"10.4049\/jimmunol.172.9.5269"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Gustin, K. M., Belser, J. A., Wadford, D. A., Pearce, M. B., Katz, J. M., Tumpey, T. M. and Maines, T. R. 2011. Influenza virus aerosol exposure and analytical system for ferrets. <i>Proc. Natl. Acad. Sci. U.S.A.<\/i> 108: 8432\u20138437.","DOI":"10.1073\/pnas.1100768108"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Hoffmann, E., Neumann, G., Kawaoka, Y., Hobom, G. and Webster, R. G. 2000. A DNA transfection system for generation of influenza A virus from eight plasmids. <i>Proc. Natl. Acad. Sci. U.S.A.<\/i> 97: 6108\u20136113.","DOI":"10.1073\/pnas.100133697"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Lai, A. C., Chambers, T. M., Holland, R. E. Jr., Morley, P. S., Haines, D. M., Townsend, H. G. and Barrandeguy, M. 2001. Diverged evolution of recent equine-2 influenza (H3N8) viruses in the Western Hemisphere. <i>Arch. Virol.<\/i> 146: 1063\u20131074.","DOI":"10.1007\/s007050170106"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Lefeber, D. J., Benaissa-Trouw, B., Vliegenthart, J. F., Kamerling, J. P., Jansen, W. T., Kraaijeveld, K. and Snippe, H. 2003. Th1-directing adjuvants increase the immunogenicity of oligosaccharide-protein conjugate vaccines related to Streptococcus pneumoniae type 3. <i>Infect. Immun.<\/i> 71: 6915\u20136920.","DOI":"10.1128\/IAI.71.12.6915-6920.2003"},{"key":"16","unstructured":"16. National Research Central on Equines (NRCE) Annual Report 2015\u20132016. India. http:\/\/nrce.gov.in\/downloads\/NRCE%20Annual%20Report%202015-2016.pdf [accessed on May 27, 2019]."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Neumann, G., Fujii, K., Kino, Y. and Kawaoka, Y. 2005. An improved reverse genetics system for influenza A virus generation and its implications for vaccine production. <i>Proc. Natl. Acad. Sci. U.S.A.<\/i> 102: 16825\u201316829.","DOI":"10.1073\/pnas.0505587102"},{"key":"18","unstructured":"18. OIE Terrestrial manual, 2016. Equine Influenza, Chapter 2.5.7., Paris: OIE. http:\/\/www.oie.int\/fileadmin\/Home\/eng\/Health_standards\/tahm\/2.05.07_EQ_INF.pdf. [accessed on April 25, 2019]."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Paillot, R., Hannant, D., Kydd, J. H. and Daly, J. M. 2006. Vaccination against equine influenza: quid novi? <i>Vaccine<\/i> 24: 4047\u20134061.","DOI":"10.1016\/j.vaccine.2006.02.030"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Pavulraj, S., Bera, B. C., Joshi, A., Anand, T., Virmani, M., Vaid, R. K., Shanmugasundaram, K., Gulati, B. R., Rajukumar, K., Singh, R., Misri, J., Singh, R. K., Tripathi, B. N. and Virmani, N. 2015. Pathology of Equine Influenza virus (H3N8) in Murine Model. <i>PLoS One<\/i> 10: e0143094.","DOI":"10.1371\/journal.pone.0143094"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Pavulraj, S., Virmani, N., Bera, B. C., Joshi, A., Anand, T., Virmani, M., Singh, R., Singh, R. K. and Tripathi, B. N. 2017. Immunogenicity and protective efficacy of inactivated equine influenza (H3N8) virus vaccine in murine model. <i>Vet. Microbiol.<\/i> 210: 188\u2013196.","DOI":"10.1016\/j.vetmic.2017.08.013"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Portuondo, D. L., Batista-Duharte, A., Ferreira, L. S., de Andrade, C. R., Quinello, C., T\u00e9llez-Mart\u00ednez, D., de Aguiar Loesch, M. L. and Carlos, I. Z. 2017. Comparative efficacy and toxicity of two vaccine candidates against Sporothrix schenckii using either Montanide<sup>TM<\/sup> Pet Gel A or aluminum hydroxide adjuvants in mice. <i>Vaccine<\/i> 35: 4430\u20134436.","DOI":"10.1016\/j.vaccine.2017.05.046"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Reed, L. J. and Muench, H. A. 1938. Simple method of estimating fifty per cent endpoints. <i>Am. J. Epidemiol.<\/i> 27: 493\u2013497.","DOI":"10.1093\/oxfordjournals.aje.a118408"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Schreiber, G. H. and Schreiber, R. D. 2003. Interferon-gamma. pp. 567\u2013602. <i>In<\/i>: The Cytokine Handbook (Thomson, A. W. and Lotze, M. T. eds.), Academic Press, San Diego.","DOI":"10.1016\/B978-012689663-3\/50028-4"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. S\u00f6rman, A., Zhang, L., Ding, Z. and Heyman, B. 2014. How antibodies use complement to regulate antibody responses. <i>Mol. Immunol.<\/i> 61: 79\u201388.","DOI":"10.1016\/j.molimm.2014.06.010"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Svitek, N., Rudd, P. A., Obojes, K., Pillet, S. and von Messling, V. 2008. Severe seasonal influenza in ferrets correlates with reduced interferon and increased IL-6 induction. <i>Virology<\/i> 376: 53\u201359.","DOI":"10.1016\/j.virol.2008.02.035"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Szyszko, E., Brokstad, K., Cox, R. J., Hovden, A. O., Madhun, A. and Haaheim, L. R. 2006. Impact of influenza vaccine formulation with a detailed analysis of the cytokine response. <i>Scand. J. Immunol.<\/i> 64: 467\u2013475.","DOI":"10.1111\/j.1365-3083.2006.01805.x"},{"key":"28","unstructured":"28. Tavakkoli, H., Asasi, K. and Mohammadi, A. 2011. Effectiveness of two H9N2 low pathogenic avian influenza conventional inactivated oil emulsion vaccines on H9N2 viral replication and shedding in broiler chickens. <i>Majallah-i Tahqiqat-i Dampizishki-i Iran<\/i> 12: 214\u2013221."},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. T\u00e9llez-Mart\u00ednez, D., Leandro Portuondo, D., Loesch, M. L., Batista-Duharte, A. and Zeppone Carlos, I. 2019. A Recombinant Enolase-Montanide\u2122 PetGel A Vaccine Promotes a Protective Th1 Immune Response against a Highly Virulent <i>Sporothrix schenckii<\/i> by Toluene Exposure. <i>Pharmaceutics<\/i> 11: 144.","DOI":"10.3390\/pharmaceutics11030144"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Topham, D. J., Tripp, R. A. and Doherty, P. C. 1997. CD8+ T cells clear influenza virus by perforin or Fas-dependent processes. <i>J. Immunol.<\/i> 159: 5197\u20135200.","DOI":"10.4049\/jimmunol.159.11.5197"},{"key":"31","unstructured":"31. Virmani, N., Bera, B. C., Singh, B. K., Shanmugasundaram, K., Gulati, B. R., Barua, S., Vaid, R. K., Gupta, A. K. and Singh, R. K. 2010. Equine influenza outbreak in India (2008\u201309): virus isolation, sero-epidemiology and phylogenetic analysis of HA gene. <i>Vet. Microbiol.<\/i> 143: 224\u2013237."},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Webster, R. G. 1993. Are equine 1 influenza viruses still present in horses? <i>Equine Vet. J.<\/i> 25: 537\u2013538.","DOI":"10.1111\/j.2042-3306.1993.tb03009.x"}],"container-title":["Journal of Veterinary Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jvms\/81\/12\/81_19-0399\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T05:14:54Z","timestamp":1695359694000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jvms\/81\/12\/81_19-0399\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":32,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1292\/jvms.19-0399","relation":{},"ISSN":["0916-7250","1347-7439"],"issn-type":[{"value":"0916-7250","type":"print"},{"value":"1347-7439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]}}}